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The Trypanosoma brucei genome encodes three groups of zinc metalloproteases, each of which contains ;30% amino
acid identity with the major surface protease (MSP, also called GP63) of Leishmania. One of these proteases, TbMSP-B,
is encoded by four nearly identical, tandem genes transcribed in both bloodstream and procyclic trypanosomes. Earlier
work showed that RNA interference against TbMSP-B prevents release of a recombinant variant surface glycoprotein
(VSG) from procyclic trypanosomes. Here, we used gene deletions to show that TbMSP-B and a phospholipase C (GPI-
PLC) act in concert to remove native VSG during differentiation of bloodstream trypanosomes to procyclic form. When
the four tandem TbMSP-B genes were deleted from both chromosomal alleles, bloodstream B
 /  trypanosomes could
still differentiate to procyclic form, but VSG was removed more slowly and in a non-truncated form compared to
differentiation of wild-type organisms. Similarly, when both alleles of the single-copy GPI-PLC gene were deleted,
bloodstream PLC
 /  cells could still differentiate. However, when all the genes for both TbMSP-B and GPI-PLC were
deleted from the diploid genome, the bloodstream B
 / PLC
 / trypanosomes did not proliferate in the differentiation
medium, and 60% of the VSG remained on the cell surface. Inhibitors of cysteine proteases did not affect this result.
These findings demonstrate that removal of 60% of the VSG during differentiation from bloodstream to procyclic form
is due to the synergistic activities of GPI-PLC and TbMSP-B.
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doi:10.1371/journal.ppat.0030150
Introduction
Trypanosoma brucei is a protozoan parasite that causes
African sleeping sickness. Its life cycle consists of several
developmental stages in its tsetse ﬂy vector and mammalian
host. In the midgut of the tsetse ﬂy, the parasites proliferate
as an extracellular procyclic (PRO) form, which have
procyclin as their major surface protein. After further
development and migration to the tsetse ﬂy’s salivary glands,
the infective trypanosomes are transmitted to the mamma-
lian host during a blood meal and differentiate into the
bloodstream form (BSF) that is also maintained extracellu-
larly in the host [1]. In a process called antigenic variation,
BSF trypanosomes evade the host immune system by
sequentially expressing different variant surface glycopro-
teins (VSGs) on their surface [2]. The T. brucei life cycle is
completed when another tsetse ﬂy ingests the parasites with
its blood meal.
BSF trypanosomes proliferate as long, slender organisms
and convert to non-proliferative, short, stumpy organisms that
are pre-adapted for differentiation to the PRO form in the
tsetse ﬂy midgut [3,4]. A distinguishing feature of the T. brucei
life cycle is the rapid shedding of the glycosylphosphatidyli-
nositol (GPI)-linked VSG coat during differentiation from
short, stumpy BSF to PRO form [5]. Several reports examining
this differentiation in vitro have identiﬁed two forms of VSG
present in the culture medium within hours of the initiation
of differentiation; one is full-length VSG protein that is
cleaved from the cell surface by a GPI-speciﬁc phospholipase
C (GPI-PLC), and the other is a truncated VSG fragment
released by a protease [6]. Recently, it has been shown that
GPI-PLC can act on surface molecules during the short,
stumpy stage and that shedding of VSG during differentiation
is also inhibited by peptidomimetic metalloprotease inhib-
itors, indicating a zinc metalloprotease is involved [7].
The parasitic protozoa Leishmania spp., which are evolutio-
narily related to T. brucei, occur as an extracellular form in
their sand ﬂy vector and an intracellular form in their
mammalian hosts’ macrophages. All Leishmania spp. contain a
major surface zinc metalloprotease (MSP, also called GP63 or
leishmanolysin), which has been studied extensively and
shown to (i) provide resistance to complement-mediated lysis
before Leishmania entry into the macrophage, (ii) participate
in attachment and entry into the macrophage, and (iii)
support survival in the macrophage after entry [8,9]. We
previously reported that the T. brucei genome contains
multiple genes encoding homologs of Leishmania MSP, which
have about 33% overall identity to one another and to
Leishmania MSP [10]. These T. brucei genes can be grouped into
three gene families (TbMSP-A, TbMSP-B, and TbMSP-C) on the
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their differential expression during the T. brucei life cycle. BSF
cells have mRNAs from all three gene families, whereas PRO
cells have detectable mRNA from only TbMSP-B. In a previous
study, we and the laboratory of Jay Bangs at the University of
Wisconsin-Madison used RNA interference (RNAi) to dem-
onstrate that T. brucei major surface protease-B (TbMSP-B)
can release a recombinant VSG from a transgenic PRO cell
line [10]. It has also been shown that when inhibitors of
transcription and translation are present during in vitro
differentiation from BSF to PRO cells, VSG shedding is
incomplete and much of it remains cell-associated [11]. These
results suggest that TbMSP-B might be the protease involved
in releasing the VSG during differentiation from short,
stumpy BSF to PRO cells.
Here, we demonstrate that TbMSP-B is a surface-localized
zinc metalloprotease that is expressed predominantly in
differentiating BSF-to-PRO cells and in established PRO cells.
When all eight genes in the TbMSP-B family were deleted
from the diploid BSF genome (B
 / cells), a delayed release of
VSG occurred during BSF-to-PRO differentiation in vitro,
but cell proliferation during differentiation was unaffected.
Likewise, when the two GPI-PLC genes were deleted from the
diploid BSF genome (PLC
 /  cells), delayed VSG release
during differentiation was also observed and cell prolifer-
ation rate was unaffected. However, when all of the genes of
both the TbMSP-B and GPI-PLC families were deleted in the
same BSF cell line (B
 / , PLC
 / ), these cells were incapable
of dividing in the differentiation medium, they had an altered
morphology compared to either wild-type (WT) or single
gene family-deleted cells (B
 /  and PLC
 / ), and they
exhibited a synergistic increase in VSG levels 96 h after
differentiation initiation. Therefore, both TbMSP-B and GPI-
PLC function in removal of VSG from the cell surface during
differentiation of T. brucei BSF cells to the PRO form.
Results
Membrane Association and Surface Labeling of TbMSP-B
Leishmania M S Pi sG P I - a n c h o r e do nt h ee x t r a c e l l u l a r
Leishmania promastigote surface, where it participates in
several functions associated with Leishmania survival in its
host [8,9]. To determine the corresponding cellular location
of TbMSP-B, we ﬁrst examined its amino acid sequence using
the computer algorithm at http://mendel.imp.univie.ac.at/gpi/
gpi_prediction.html, which predicted that nascent TbMSP-B
has an N-terminal hydrophobic signal sequence (residues 1–
30) and a C-terminal cleavage site for the addition of a GPI
anchor at residue 530. The C-terminal sequence is positioned
in front of a stretch of seven amino acids that constitute a
hydrophilic spacer region, followed by a C-terminal hydro-
phobic region of 15 residues [12]. The presence of these N-
and C-terminal hydrophobic sequences stimulated additional
experiments to determine if TbMSP-B is membrane-associ-
ated and possibly located on the cell surface.
Triton (TX)-114 extraction experiments were used to see if
TbMSP-B fractionates as an integral membrane protein, as
expected from its predicted GPI anchor. Figure 1A shows a
schematic representation of the TX-114 extraction protocol
used to separate the hydrophilic (aqueous phases) proteins
from the integral membrane proteins (detergent phase).
Brieﬂy, PRO cells were solubilized in TX-114 and separated
into an aqueous and detergent phase by raising the temper-
ature above the TX-114 cloud point followed by centrifuga-
tion (Aq1 and D1 in Figure 1A). To ensure complete
separation, these phases were again extracted with TX-114
and additional aqueous and detergent phases were isolated
(Aq1–2, D2, and Aq2). The circled phases were then evaluated
using western blots.
To facilitate these experiments and enhance the TbMSP-B
signal, a PRO cell line was generated that contains the
integrated plasmid, pLEW82/TbMSP-B, from which TbMSP-B
is overexpressed when induced with tetracycline (see Materi-
als and Methods). PRO cells without the integrated plasmid
and PRO cells bearing the integrated pLEW82/TbMSP-B
expression plasmid were grown in the absence (  Tet) or
presence (þ Tet) of tetracycline and extracted with TX-114,
and the aqueous and detergent phases were analyzed for the
presence of TbMSP-B and HSP-70. Endogenous TbMSP-B was
found exclusively in the detergent fractions of PRO cells and
the uninduced overexpression PRO cell line (Figure 1B, lanes
4 and 8 respectively), indicating it is a membrane protein.
When the pLEW82/TbMSP-B cell line was tetracycline-
induced to overexpress the protein, TbMSP-B was found
predominantly in the detergent phase. Although a small
percentage was present in the intermediate Aq1 fraction, it
did not appear in the fully extracted Aq1–2 fraction,
indicating it is not a soluble cytosolic or peripheral
membrane protein (Figure 1B, lanes 9–12). The smaller
additional bands observed in lane 12 are likely degradation
products of the highly synthesized protein. To verify the
expected partitioning of cytosolic and membrane proteins in
the procedure, the same phases were probed with antiserum
directed against heat shock protein 70 (HSP-70) (Figure 1C).
The presence of HSP-70 in the Aq1 and Aq1–2 phases shows
that cytosolic proteins were separated from membrane
proteins in the experiment and that TbMSP-B is a membrane
protein.
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Author Summary
African trypanosomes cause sleeping sickness, a fatal disease of
humans and livestock in Africa. During their life cycle, these
protozoan parasites cycle between the bloodstream of mammals
and tsetse flies. Their two main developmental stages are the
bloodstream form and the procyclic form in the tsetse fly.
Bloodstream trypanosomes thwart their host’s immune response
by periodically switching their major surface protein, the variant
surface glycoprotein (VSG). When bloodstream trypanosomes are
ingested by a tsetse fly, they must quickly shed the VSG and replace
it with an unrelated invariant protein more suited to their survival as
procyclic organisms in the fly midgut. Here, we examine the
mechanisms used by trypanosomes to remove the VSG during their
differentiation from bloodstream to procyclic form in culture. We
deleted the genes for one of the trypanosome’s protease enzymes
from the trypanosome genome and found that bloodstream
trypanosomes could still differentiate to the procyclic form, but
VSG removal was diminished. Deleting the genes for a phospholi-
pase enzyme had a similar effect—they could still differentiate but
VSG removal was impaired. When the genes for both the protease
and the phospholipase were deleted, bloodstream trypanosomes
could not differentiate to the procyclic form, they retained about
60% of the VSG on their surface, and they died in the differentiation
medium. These results highlight the synergistic roles of these two
enzymes in the differentiation process.After multiple inconclusive attempts to determine the
location of TbMSP-B using immunoﬂuorescence microscopy,
likely due to inability of our antisera to recognize the native
protein during microscopy, we adopted the biochemical
approach of utilizing biotin surface labeling to see if TbMSP-
B is present on the cell surface. The general strategy for the
biotin labeling/immunoprecipitation experiment is shown in
Figure 2A. PRO cells were biotin-labeled, followed by
immunoprecipitation with antiserum directed against the
protein of interest and separation of the immunoprecipitated
protein (pellet [P]) from the unbound proteins (supernatant
[S]). PRO cells bearing stably integrated pLEW82/TbMSP-B
were biotin-labeled after the culture had been split and
grown either in the absence or presence of 1 lg tetracycline/
ml medium for 24 h. The biotin-labeled cell extracts were
immunoprecipitated with afﬁnity-puriﬁed TbMSP-B antise-
rum and separated into pellet and supernatant fractions.
Western blot analysis using a streptavidin-HRP antiserum to
detect biotin-labeled proteins revealed that TbMSP-B in
uninduced cells, i.e., likely the native TbMSP-B protein, was
biotin-labeled during the procedure (Figure 2B). It also
showed that the additional TbMSP-B expressed in the
presence of tetracycline was likewise accessible to biotin
labeling (Figure 2B,þTet). To control for the possibility that
all cellular proteins were biotin-labeled, and not only the
surface proteins, PRO cells were biotin-labeled as before and
cell extracts were immunoprecipitated with HSP-70 anti-
serum (Figure 2C) and BiP antiserum (not shown). Figure 2C,
lanes 1 and 2, show the pellet (P) and supernatant (S) fractions
from the biotin labeling/immunoprecipitation procedure in
which the western blot was incubated with the streptavidin-
HRP antibody. No biotin-labeled HSP-70 protein migrating
at 70 kDa (and no BiP; not shown) was detected in either the P
or S fractions, conﬁrming that cytosolic proteins were not
biotin labeled. The smeared band of protein below 48 kDa in
lane 2 is likely the abundant biotin-labeled EP-procyclin that
did not bind to the HSP-70 antiserum. The other weak band
at 63 kDa could be endogenous TbMSP-B, while the distinct,
weak band at 82 kDa represents an unidentiﬁed biotin-
labeled protein. The presence of HSP-70 in each fraction was
veriﬁed by performing a western blot of the fractions (Figure
2C, lanes 3 and 4). HSP-70 protein was identiﬁed in the pellet
fraction (P) with an approximate size of 70 kDa along with a
strong band of IgG molecules (55 kDa) carried through
during the immunoprecipitation process. Thus, both endog-
enous and overexpressed TbMSP-B is accessible to surface
biotinylation of live PRO cells.
TbMSP-B Is a Zinc Metalloprotease
TbMSP-B is predicted on the basis of its amino acid
sequence to be a modiﬁed member of the metzincin class of
zinc proteinases [13]. It has a conserved zinc metalloprotease
catalytic site sequence of HEXXHXXG as well as other
conserved residues, indicating that TbMSP-B could function
as a protease in T. brucei. Endogenous TbMSP-B protease
activity was initially difﬁcult to detect, possibly because of low
abundance of the protein. Thus, we used PRO cells bearing
pLEW82/TbMSP-B to examine whether tetracycline-induced
TbMSP-B has protease activity. The PRO cells were grown in
the absence or presence of tetracycline for 24 h and
processed for zymogram gel analysis. In the extracts of PRO
cells overexpressing TbMSP-B, a clear proteolytic band
appears at 60 kDa (Figure 3, lane 2, and arrow). When these
same extracts were treated with 1, 10 phenanthroline, a zinc
metalloprotease inhibitor, no proteolytic cleavage of the
casein substrate in the 60-kDa region of the gel was observed
(Figure 3, lanes 5 and 6). It should be noted also that TbMSP-
B appears to have some substrate speciﬁcity because control
Leishmania extracts exhibited MSP activity on both casein and
gelatin substrates, whereas TbMSP-B only showed activity on
a casein substrate (unpublished data). The signiﬁcance of this
observation is still under investigation.
Figure 1. TbMSP-B Is an Integral Membrane Protein
(A) Summary of the TX-114 extraction protocol used to separate trypanosome cytosolic proteins (Aq phases) and integral membrane proteins (D
phases). Circled fractions were used in the western blots shown in the other panels.
(B and C) PRO cells (lanes 1–4) and PRO cells containing integrated pLEW82/TbMSP-B, either not induced (lanes 5–8) or induced (lanes 9–12) with 1 lg
tetracycline/ml, were subjected to TX-114 extraction and analyzed by western blots probed with antisera directed against (B) TbMSP-B (a TbMSP-B) and
(C) HSP-70 (a HSP-70) as a control to detect a cytosolic protein and confirm purity of extraction phases.
doi:10.1371/journal.ppat.0030150.g001
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A Trypanosome MetalloproteaseLeishmania MSP metalloprotease activity depends on the
presence of the HEXXH catalytic motif. McGwire and Chang
[14] generated several mutations within the Leishmania MSP
active site and determined that glutamate at position 265 was
necessary for protease activity, but not for protein stability.
To better deﬁne the TbMSP-B catalytic domain, we con-
ducted a similar study by introducing a site-speciﬁc mutation
within the predicted active site. Plasmid pLEW82/TbMSP-B
was used as a template in the Stratagene QuickChange Site-
Directed Mutagenesis procedure to generate a pLEW82/
TbMSP-BE233D mutant in which E in the catalytic motif was
converted to D. The entire TbMSP-B coding region in this
mutant was sequenced to conﬁrm that no other mutation had
been introduced. This mutant plasmid was stably integrated
into the genome of PRO cells, selecting for bleomycin
resistance. This cell line was grown in the absence (Figure 3,
lane 3) and presence (lane 4) of tetracycline for 24 h and
processed for zymogram gel analysis. The overexpressed
TbMSP-BE233D did not exhibit detectable protease activity
(lane 4 and arrow) despite the presence of three times the
amount of cell extract compared to the WT TbMSP-B
extracts in Figure 3A, lanes 1 and 2. Western blot analysis
of tetracycline-induced cells bearing pLEW82/TbMSP-BE233D
veriﬁed TbMSP-BE233D expression under these conditions
(unpublished data). These experiments demonstrate that
TbMSP-B has zinc metalloprotease activity.
Deletion of the TbMSP-B and GPI-PLC Genes
Initially, multiple experiments with BSF cells were con-
ducted using RNAi directed against TbMSP-B mRNA to see
what the effect of diminishing the steady state level of
TbMSP-B would be on growth of BSF cells and on their
differentiation to PRO cells in culture. However, in repeated
experiments using cloned BSF cells bearing tetracycline-
inducible TbMSP-B RNAi plasmids, it was not possible to
completely eliminate TbMSP-B mRNA from the cells,
especially during differentiation from BSF to PRO in culture.
Thus, we decided to delete all of the TbMSP-B genes from the
diploid genome of BSF cells, reasoning that BSF cells might
not need TbMSP-B because preliminary western blots showed
that in BSF cells it is in very low abundance or non-existent.
The TbMSP-B gene (TbMSP-B) cluster is on chromosome
VIII [10]. The four tandem TbMSP-Bs in this cluster have 99%
nucleotide identity and encode proteins with 99% amino acid
identity. To delete the four tandem TbMSP-B genes on each
chromosome VIII (Figure 4A), fragments of approximately 0.4
kb upstream of the gene cluster and 2.3 kb downstream were
PCR-ampliﬁed from the genome, and cloned into sites on a
plasmid that ﬂank a DNA segment bearing either the
hygromycin (HYG
R) or bleomycin (BLE
R) antibiotic resistance
gene containing the 59 and 39 UTRs of the T. brucei actin gene.
The resultant cassettes were excised from the plasmid and
targeted sequentially into the TbMSP-B loci of BSF cells via
electroporation. The expectation was that the ﬁrst trans-
fection (HYG
R selection) would delete one allele and the
second transfection (BLE
R selection) would delete the other
allele. HindIII-digested genomic DNAs from WT BSF cells,
two independent BSF cell lines transfected sequentially with
both TbMSP-B deletion cassettes, as well as one BSF cell line
transfected only with the HYG
R deletion cassette, were
analyzed by Southern blot for the presence of HYG
R, BLE
R,
and TbMSP-B coding sequence (Figure 4B). As expected,
HYG
R (;1.5 kb) was present in the transfected cell lines (lanes
2–4), and absent from the WT BSF cell line (lane 1). When
probed with BLE
R, two of the transfected cell lines were
found to have this sequence (lanes 6 and 7), while the third
cell line only transfected with the HYG
R cassette did not
contain it (lane 8). This cell line must have undergone two
separate recombination events in which both alleles of the
TbMSP-B gene cluster were replaced with the HYG
R cassette.
When DNAs from each of the cell lines were probed with
Figure 2. TbMSP-B Can Be Surface Biotinylated
(A) Summary of the biotinylation and immunoprecipitation protocol used to detect proteins on the surface of PRO cells that are labeled with biotin.
PRO cells were surface biotin-labeled with EZ-Link Sulfo-NHS-Biotin (Pierce), followed by cell lysis and immunoprecipitation (IP) of cell extracts with
antiserum directed against TbMSP-B or HSP-70.
(B) PRO cells bearing integrated pLEW82/TbMSP-B were not induced (  Tet) or induced (þ Tet) with 1 lg tetracycline/ml for 24 h prior to surface
biotinylation and immunoprecipitation with affinity-purified MSP-B antiserum (a TbMSP-B). Proteins in the pellet fraction (P) were separated on an SDS-
PAGE gel, and surface biotin-labeled proteins were visualized using an avidin-HRP secondary antibody.
(C) PRO cells were surface biotinylated and rabbit HSP-70 antiserum (a HSP-70) was used to immunoprecipitate HSP-70 protein from the cell extracts. In
lanes 1 and 2, the pellet (P) and supernatant (S) fractions are shown in which biotin was the primary label, followed by visualization of the biotin-labeled
proteins with secondary avidin-HRP. The major band in lane 2 is biotin-labeled procyclin. Lanes 3 and 4 show a western blot in which the P and S
fractions were incubated with rabbit HSP-70 antiserum followed by an anti-rabbit-HRP secondary antibody.
doi:10.1371/journal.ppat.0030150.g002
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A Trypanosome MetalloproteaseTbMSP-B, WT cells showed strong hybridization to two
TbMSP-B fragments of 2.1 and 3.2 kb as expected (lane 9),
and TbMSP-B was absent from the other three cell lines (lanes
10–12). The TbMSP-B
 /  cell line (B
 /  cells) represented in
lanes 4, 8, and 12 was used in future experiments and in
generating cell lines in which the genes for both TbMSP-B
and GPI-PLC were deleted (B
 /  PLC
 /  cells; Figure 4E and
below).
GPI-PLC has been implicated in removing the VSG from
the cell surface via cleavage of the GPI anchor during T. brucei
differentiation [6,12,15]. This earlier work deleted the two
allelic (single-copy) GPI-PLC genes from another parental cell
line and showed that GPI-PLC is not essential for normal
differentiation because this BSF PLC
 /  cell line was still
capable of differentiating and completing its life cycle. Figure
4C is a schematic representation of the GPI-PLC deletion
strategy used in this work to delete both gene copies from the
diploid T. brucei genome. The genes were replaced with
cassettes containing either the puromycin (PUR
R) or the
bleomycin (BLE
R) antibiotic resistance gene. The PUR
R
deletion plasmid was transfected ﬁrst into WT BSF cells
(Figure 4D, lane 1), followed by an additional transfection
with the BLE
R construct. Three GPI-PLC
 /  cell lines were
selected from this second transfection (lanes 2–4). Finally, to
deﬁne the roles of both TbMSP-B and GPI-PLC during
differentiation, a doubly deleted cell line (B
 /  PLC
 / ), was
generated using the B
 /  cell line in which the HYG
R cassette
had replaced both alleles of the four-repeat TbMSP-B gene
cluster (Figure 4B, lanes 4, 8, and 12). The B
 /  cell line was
ﬁrst stably transfected with the linearized PUR
R plasmid
(Figure 4E, lane 1) followed by a second transfection with the
linearized BLE
R construct (Figure 4E, lanes 2–4). The
establishment of the three different deletion cell lines, B
 / ,
PLC
 / , and B
 /  PLC
 / , allowed us to determine if these
gene products, either alone or jointly, contribute to the
release of VSG during differentiation and if either or both
are necessary for differentiation.
Growth and Differentiation of Deletion Cell Lines
The growth of the WT BSF cells was compared to that of
each type of the genomic deletion cell lines under normal
BSF culture conditions over a 3-d period (Figure 5A). No
signiﬁcant difference in growth was observed for any cell line,
conﬁrming previous reports that TbMSP-B and GPI-PLC are
not necessary for normal BSF cell growth [9,16], as well as
establishing that BSF cells lacking both TbMSP-B and GPI-
PLC grow normally under these conditions.
To test whether TbMSP-B or GPI-PLC or both are
important during the differentiation process, all three
deletion cell lines, as well as WT cells, were induced to
differentiate from BSF to PRO form. The BSF cell lines were
ﬁrst treated for 48 h with a membrane-permeable derivative of
cyclic adenosine monophosphate (cAMP), 8-(4-chlorophe-
nylthio)-cAMP (dCPTcAMP), to stimulate conversion from
proliferating long, slender BSF to non-proliferative, short,
stumpy BSF [17], and then placed in PRO medium at 26 8Cf o r
differentiation from short, stumpy BSF to PRO form. Cell
growth was monitored at 24-h intervals. No differences in
growth rate was observed for the WT, B
 / , and PLC
 /  cell
lines during differentiation, but the B
 /  PLC
 /  cell line was
not able to divide at the same rate in the differentiation
medium (Figure 5B, 0–96 h). During the ﬁrst 48 h of
differentiation (0–48 h) the three other cell lines multiplied
with a doubling time of approximately 48 h, whereas the B
 / 
PLC
 / cell line showed a only modest increase in cell count to
2.6 3 10
6 cells/ml (Figure 5B, 96 h) from the starting
concentration of 2.0 3 10
6 cells/ml (0 h). Cell morphology
during differentiation was also documented for each cell line.
All four cell lines had very similar morphology as long, slender
BSF cells in the BSF growth medium (Figure 5C, WT BSF cells
shown at time  48 h for reference). After 48 h growth in
cAMP, long, slender cells had transformed to the short, stumpy
form in all cell lines (Figure 5D, B
 /  PLC
 /  BSF cells shown
for reference), but the doubly deleted cell line exhibited an
altered morphology from 48 h through 96 h (Figure 5F versus
Figure 5E). The B
 /  PLC
 /  cells were enlarged with multiple
nuclei and kinetoplasts, and often had detached ﬂagellae. The
morphological differences of these cells compared to WT and
the single-deleted cell lines, along with their lack of cell
division, indicate that the presence of both TbMSP-B and GPI-
PLC is essential for normal cell differentiation.
TbMSP-B Expression and VSG Release during
Differentiation
Many changes in gene expression are known to occur
during T. brucei differentiation from BSF to PRO [18]. Among
Figure 3. TbMSP-B Is a Zinc Metalloprotease
(A) PRO cells containing integrated pLEW82/TbMSP-B or pLEW82/TbMSP-
BE233D were either not induced (  Tet) or induced (þ Tet) with 1 lg
tetracycline/ml for 24 h, collected, and resuspended in non-reducing,
denaturing Laemmli sample buffer. About 10
7 cell equivalents were
electrophoresed on a 12% casein zymogram gel followed by overnight
incubation in development buffer in the absence ( ) or presence (þ)o f
the zinc metalloprotease inhibitor 1, 10 phenanthroline. After staining
with Commassie blue dye and destaining, proteolytically cleaved gel
substrate appeared as a clear band in the 60-kDa range (arrow and lane
2). The proteolytic activity was not observed in extracts from cells
bearing pLEW82/TbMSP-BE233D (lane 4). Note that three times the cell
equivalents were loaded in assessing the proteolytic activity of this
mutant TbMSP (lanes 3–4). Incubation of the zymogram gel in
development buffer supplemented with 1, 10 phenanthroline resulted
in severely diminished TbMSP-B protease activity (compare lanes 2 and
6).
doi:10.1371/journal.ppat.0030150.g003
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A Trypanosome Metalloproteasethese changes, VSG transcription is substantially reduced
during the ﬁrst 4 h, and VSG protein is not detected in cells
after approximately 48 h ([12,19] and Figure 6B). The two
forms of procyclin, GPEET- and EP-procyclin, are expressed
early in differentiation and replace the VSG as the predom-
inant cell surface proteins. GPEET-procyclin then decreases,
whereas the EP form continues to be expressed and occurs on
the surface of PRO cells [20]. We have previously shown that
TbMSP-B mRNA is present in both BSF and PRO cells [10].
Thus, we examined whether TbMSP-B protein is also found in
both life cycle stages and what, if anything, happens to its
expression during differentiation. Extracts from each of the
four cell lines shown in the differentiation growth analysis in
Figure 5B were analyzed by western blots for the presence of
TbMSP-B (Figure 6A). WT BSF cells—both long, slender ( 48
h) and short, stumpy forms (0 h)—expressed little, if any,
detectable amounts of TbMSP-B protein despite the presence
of its RNA ([10] and unpublished data), but TbMSP-B was
readily detected 24 h after the cells were placed in PRO
medium. TbMSP-B protein expression was highest at the 24-h
time point, but remained higher for the entire 96-h differ-
entiation period than in PRO cells continually grown at 26 8C
in PRO medium. PLC
 /  cells showed a similar pattern of
TbMSP-B expression. No TbMSP-B was detected at any time
point in either the B
 /  or the B
 /  PLC
 /  cell lines.
VSG221, the VSG expressed by these BSF cells, was gone
Figure 4. Generation of T. brucei BSF Cell Lines Bearing Gene Deletions
(A) The strategy for deleting the cluster of four tandem TbMSP-B genes from both alleles of chromosome VIII utilized 0.4 kb of sequence upstream of
the cluster and 2.3 kb of sequence downstream. The cassette used for the deletions contained either the HYG
R or BLE
R gene for selection with the
appropriate antibiotic.
(B) Analysis of three cloned MSP-B
 / cell lines (B
 / ). The HYG
R cassette was transfected first into the WT BSF cell line, followed by transfection with the
BLE
R cassette. Southern blots of genomic DNAs from WT and three cloned B
 /  cell lines cleaved with XhoI and StuI were probed with the coding
regions of HYG
R (lanes 1–4) or BLE
R (lanes 5–8), and the same genomic DNAs cleaved with HindIII were probed with the coding sequence of TbMSP-B
(lanes 9–12). Lanes 4, 8, and 12 show a cell line that does not contain the BLE
R gene but does lack all copies of the TbMSP-B gene (see text). This B
 / 
cell line was used in differentiation experiments and to generate doubly deleted B
 /  PLC
 /  cell lines (see [E]).
(C) Strategy for generating PLC
 /  cell lines. Both alleles of the single-copy GPI-PLC gene were replaced with cassettes containing either the BLE
R or
PUR
R gene flanked by a 0.8-kb upstream and 1.1-kb downstream genomic sequence.
(D) Southern blot of genomic DNAs from WT BSF cells and three BSF PLC
 /  cell lines cleaved with NdeI and probed with the PLC coding sequence.
(E) Southern blots of genomic DNA from a B
 /  cell line transfected with the GPI-PLC deletion cassettes. The B
 /  cell line shown in lane 12 of (B) was
transfected first with the PLC/BLE
R cassette (lane 1). The resulting B
 /  PLC
 /þ cell line in lane 1 was then transfected with the PLC/PUR
R cassette to
generate a doubly deleted cell line, three clones of which are shown in lanes 2–4. The genomic DNAs were cleaved with NdeI and probed with the PLC
coding sequence.
doi:10.1371/journal.ppat.0030150.g004
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 / 
and B
 /  cells through the 96 h-time point at gradually
decreasing levels. The reason for the presence of two VSG221
protein bands in WT and B
 /  cell extracts (Figure 6B) is not
known. Treatments with two separate reducing compounds,
beta-mercaptoethanol and dithiothreitol, did not eliminate
the double bands. When both TbMSP-B and PLC were deleted
from the genome, about 60% of the VSG remained on the
cells 96 h after differentiation was initiated (Figures 6B and
7). Thus, both TbMSP-B and GPI-PLC participate in the loss
of VSG during differentiation and may act synergistically.
Figure 7 summarizes densitometry measurements of the loss
of VSG from WT cells and the three deletion cell lines. Note
that the B
 /  PLC
 /  cells retain about 60% of their VSG
after 48 h in the differentiation medium, and do not lose any
more during the next 48 h. During this same time, these cells
acquire abnormal shapes and do not divide (Figure 5B and
5F).
The procyclin proteins were expressed as expected in the
differentiating cells. EP-procyclin was detected in all cell lines
within 24 h of transfer to PRO medium at 26 8C (Figure 6C).
However, more EP-procyclin was present in both of the B
 / 
cell lines than in the WT cells throughout the differentiation
process. The signiﬁcance of this observation is still under
investigation, but it might suggest that TbMSP-B cleaves
procyclin to a small extent. GPEET-procyclin expression
occurred early in differentiation as previously reported [20]
and disappeared in WT and PLC
 /  cells by 72 h (Figure 6D).
This protein expression pattern was also slightly modiﬁed in
both of the B
 /  cell lines in that more GPEET-procyclin was
present at the later time points. Figure 6E shows a western
blot probed with tubulin antiserum to conﬁrm equivalent
loading of cell samples.
The Differentiation Medium Contains VSG Protein
Previous studies of a transgenic PRO cell line engineered to
express a recombinant VSG revealed that RNAi knock-down
of TbMSP-B mRNA resulted in reduced release of the VSG
from the cell surface into the medium [10]. This information,
along with the fact that TbMSP-B only appears when BSF cells
Figure 5. Single and Double Knock-Out BSF Cell Lines Grow Normally as BSF Cells, but B
 /  PLC
 /  Cells Exhibit a Growth Defect in Differentiation
Medium
(A) BSF WT (diamonds), B
 /  (triangles), PLC
 /  (squares), and B
 /  PLC
 /  (x) cells all grow at the same rate in bloodstream culture.
(B) The doubly deleted B
 / PLC
 /  cells (x) do not divide in the differentiation medium, whereas the WT, B
 / , and PLC
 /  cells have a doubling time
of approximately 48 h.
(C) Phase contrast imaging and DAPI staining of a WT cell prior to treatment with pCPTcAMP.
(D) Phase contrast imaging and DAPI staining of a short, stumpy B
 /  PLC
 /  cell after 48 h of treatment with pCPTcAMP.
(E) Phase contrast imaging and DAPI staining of a WT cell after 72 h in differentiation medium.
(F) Phase contrast imaging and DAPI staining of a B
 /  PLC
 /  cell after 72 h in differentiation medium.
The scale bar in (C–F) indicates 5 lm.
doi:10.1371/journal.ppat.0030150.g005
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the culture medium to determine whether TbMSP-B is
responsible for release of a speciﬁc form of VSG during
differentiation. Three time points were selected:  48 h (long,
slender BSF cells), 0 h (short, stumpy BSF cells), and 48 h after
the start of differentiation. Western blot analysis of the
culture medium from WT cells probed with VSG221
antiserum showed a 48-kDa VSG band at the  48 and 0 h
time points (Figure 8A, lanes 1 and 2), and two VSG bands
(48- and 37-kDa) after 48 h of differentiation (lane 3). In the
absence of GPI-PLC, a similar pattern of 48- and 37-kDa VSG
bands is seen (Figure 8A, lanes 4–6). However, in the absence
of TbMSP-B (B
 /  cells and B
 /  PLC
 /  cells), the 37-kDa
VSG fragment does not occur in the differentiation medium
(Figure 8A, lanes 7–9 and 10–12), suggesting TbMSP-B is
responsible for it. The VSG in the medium of the B
 / PLC
 / 
cell line (lanes 10–12) occurs as a double band in the 48-kDa
region, for reasons as yet unknown. The relative intensities of
the bands in the three lanes for each cell line (the 48, 0, and
48 lanes) varied from one experiment to another (not shown),
so it was not possible to ascribe signiﬁcance to these relative
VSG intensities in the medium. In contrast, the relative
intensities of the VSG bands derived from the differentiating
cells at different time points (Figure 6B) varied little among
independent experiments.
The ﬁlter shown in Figure 8A was stripped and reprobed
with antiserum directed against the cross-reacting determi-
nant (CRD) found on VSG protein that has been cleaved by
GPI-PLC [21]. This analysis was conducted to conﬁrm that the
37-kDa fragment is not due to release by a phospholipase.
Figure 8B shows that the CRD antiserum detected the 48-kDa
VSG from the WT and B
 / cells but did not recognize the 37-
kDa VSG fragment, again suggesting this smaller VSG
fragment occurs as a result of proteolytic release. The CRD
antiserum did not detect proteins in the medium samples of
either of the PLC
 /  cell lines (Figure 8B, lanes 4–6 and 10–
12) even though VSG was present in those samples. This result
suggests that additional enzymes may also be involved in the
release of VSG into the medium.
Figure 6. Expression of TbMSP-B, VSG, and Procyclin Proteins by WT and Gene-Deleted Cells during Differentiation from BSF to PRO
Each cell line was treated with pCPTcAMP (cAMP) for 48 h ( 48 to 0 h) to stimulate the transition of long, slender BSF cells to the short, stumpy form. At
time 0, the short, stumpy BSF cells were centrifuged from BSF medium, resuspended in PRO medium containing 3 mM cis-aconitate/citrate, and placed
at 26 8C to induce differentiation to PRO cells. Cells were collected at the time points indicated (h) and whole cell extracts were analyzed by western
blots. The extracts were probed with antiserum directed against (A) TbMSP-B (a TbMSP-B), (B) VSG221 (a VSG221), (C) EP-procyclin (a EP-Procyclin), (D)
GPEET-procyclin (a GPEET-Procyclin), and (E) a-tubulin (a TUB) as a control for equal loading. The lanes labeled PRO contain an extract of PRO cells
grown continuously at 26 8C in PRO medium.
doi:10.1371/journal.ppat.0030150.g006
Figure 7. VSG Levels during BSF-to-PRO Differentiation
The VSG bands on the western blot shown in Figure 6B were quantitated
by densitometry for each of the four cell lines during BSF-to-PRO
differentiation. The VSG intensities were normalized to the tubulin levels
at each time point and the initial VSG level ( 48 h) for each cell line was
set at 100%. The VSG level shown for each time point is a percentage of
initial VSG levels. The amounts of VSG remaining in B
 /  (triangles), PLC
 /  (squares), and B
 /  PLC
 /  (x) cells all decline more slowly than that
of WT (diamonds) cells during differentiation. At 96 h, B
 /  PLC
 /  cells
have approximately 60% VSG remaining, compared to 16%, 5%, and 0%
in PLC
 / ,B
 / , and WT cells, respectively.
doi:10.1371/journal.ppat.0030150.g007
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To conﬁrm that TbMSP-B contributes to the release of
VSG during differentiation, the WT or mutant TbMSP-B gene
was added back to the genome of the B
 /  cell line (Figure 9).
Plasmids pLEW82/TbMSP-B or pLEW82/TbMSP-BE233D were
stably transfected into the rRNA gene locus of B
 /  cells to
generate B
 /  (TbMSP-B)o rB
 /  (TbMSP-BE233D) cells. These
two cell lines were taken through the same differentiation
process as described above. Cell samples were collected at 24-
h intervals and analyzed for TbMSP-B and VSG protein by
western blot. Tetracycline was added to each differentiating
cell culture at 0 and 48 h to induce the expression of TbMSP-
B or TbMSP-BE233D from the integrated pLEW82 plasmid.
Figure 9A shows that TbMSP-B and TbMSP-BE233D were
expressed from 24 h on through the differentiation. TbMSP-
BE233D was expressed at slightly lower levels than WT TbMSP-
B, a repeatable observation, but was still expressed at levels
higher than endogenous TbMSP-B in PRO cells (Figure 9A,
lane 13). The complementation of the B
 /  cell line with WT
TbMSP-B resulted in the loss of VSG by 48 h (Figure 9B, lanes
1–6), similar to that observed when WT BSF cells differ-
entiate. In contrast, addition of TbMSP-BE233D did not lead to
a similar VSG loss as the protein was detected through 96 h
(Figure 9B, lanes 7–12), similar to that of B
 /  cells.
In addition to the above evidence, western blot analysis
conﬁrmed TbMSP-B as necessary for release of the 37-kDa
VSG fragment into the medium when WT BSF cells differ-
entiate to the PRO form, as observed in Figure 8A, lanes 3
and 6. Complementation of B
 /  cells with the WT TbMSP-B
(Figure 10, lanes 1–3) again resulted in appearance of a 48-
kDa VSG protein and a 37-kDa VSG fragment the medium. In
these experiments, a small amount of the 37-kDa fragment
was present prior to the addition of tetracycline at 0 h, when
no TbMSP-B protein is detected. The simplest explanation of
this result is that in the absence of tetracycline there is a low
level of leaky TbMSP-B expression from integrated pLEW82/
TbMSP-B, which is below our detection capabilities with this
TbMSP-B antibody. The 37-kDa VSG fragment is more
abundant at 48 h and is only present when WT TbMSP-B
was reintroduced. The 48-kDa VSG protein is the only form
present in the culture medium from B
 / cells complemented
with TbMSP-BE233D (Figure 10, lanes 4–6). Thus, an active
TbMSP-B protease is necessary for release of the 37-kDa VSG
fragment during differentiation.
Cysteine Protease Treatment of Differentiating Cells
The observation that about 40% of the VSG is still released
from differentiating B
 / PLC
 / cells (Figure 7) prompted us
to investigate whether cysteine protease inhibitors would
interfere with this VSG release, because it has been reported
[22] that cysteine protease inhibitors partially interfere with
VSG release during differentiation. WT and B
 /  PLC
 /  BSF
cells were induced to differentiate as described for Figure 6,
except that the cysteine protease inhibitors P27 or K11777
were added to a ﬁnal concentration of 2 lM [22] when the
cells were transferred to PRO medium. As shown in Figure 11,
western blot analysis of cell extracts during differentiation
was used to determine the VSG221 levels in the absence of the
cysteine protease inhibitors (no cysPI), or in the presence of
P27 or K11777. In the absence of these inhibitors, VSG was
Figure 8. Released VSG221 Protein Occurs in the Culture Medium of BSF Cells and BSF-to-PRO Differentiating Cells
Cultured logarithmic WT and gene-deleted BSF cells were subjected to centrifugation and supernatants were collected prior to pCPTcAMP (cAMP)
addition ( 48), prior to resuspension of cells in PRO medium (0) and 48 h after differentiation was initiated. Aliquots of the supernatants were probed in
western blots with (A) antiserum against VSG221 (a VSG221) and (B) then stripped and reprobed with antiserum against the cross-reactive determinant
(a CRD) found on GPI-anchored proteins hydrolyzed by GPI-PLC.
doi:10.1371/journal.ppat.0030150.g008
PLoS Pathogens | www.plospathogens.org October 2007 | Volume 3 | Issue 10 | e150 1440
A Trypanosome Metalloproteasecompletely released from WT cells by 72 h of differentiation
(Figure 11A). The addition of each of the cysteine protease
inhibitors increased the levels of VSG present on the cells at
96 h of differentiation from 0% to 10%–20%, consistent
with, but not as dramatic as, the 50% seen previously [22].
However, treatment of B
 / PLC
 / cells with these inhibitors
during differentiation (Figure 11B) did not reveal a signiﬁ-
cant difference in VSG levels compared to non-treatment
(also compare with Figures 6B and 7).
Finally, western blot analysis (not shown) of the differ-
entiation culture medium in the presence of the two cysteine
protease inhibitors revealed an identical VSG pattern in the
medium to that observed when examining WT and B
 /  PLC
 /  supernatants (Figure 8A). The inhibitor treatment of WT
cells had no effect on the presence of both the 48-kDa and the
37-kDa VSG proteins in the medium 48 h after the start of
differentiation. Likewise, the medium of B
 /  PLC
 /  cells
treated with these inhibitors contained the same 48-kDa VSG
as the untreated cells.
Discussion
Here, we used a monomorphic BSF cell line deleted in the
genes for either TbMSP-B or GPI-PLC, or both, to show that
(i) TbMSP-B is the zinc metalloprotease involved in VSG loss
during differentiation, and (i) TbMSP-B and GPI-PLC
participate synergistically in VSG loss during BSF-to-PRO
differentiation. The differential expression of TbMSP-B is
consistent with its involvement in VSG loss during differ-
entiation. It is not expressed to an appreciable extent in long,
slender or short, stumpy BSF cells, but it appears a few hours
after the start of differentiation and remains present in
established PRO cells (Figure 6A). TbMSP-B is also localized
on the cell surface in PRO cells as determined by biotin-
labeling experiments (Figure 2B). Since we were unable to
successfully use immunolocalization with the anti-TbMSP-B
serum to determine the exact location of TbMSP-B, its site on
the cell surface remains under investigation, but several
possibilities exist. It could be located in the ﬂagellar pocket
during differentiation, as suggested by Ziegelbauer et al. [6],
positioning it for access to the continually endocytosed and
recycled VSG protein [23]. Alternatively, it might be
distributed across the cell membrane during the early hours
of differentiation when VSG is removed from the cell surface.
Glutamate at position 265 (E265) has been shown in a
Leishmania MSP to be required for its protease activity,
whereas changes at several other residues reduced protein
stability but not enzyme activity [14]. We utilized a similar
mutation strategy to examine the equivalent glutamate within
the conserved HEXXH sequence (-H232EIAH236-) of TbMSP-B
[10]. The conservative substitution of E233 to D233—an amino
Figure 10. Truncated VSG221 Protein Occurs in the Culture Medium of
Differentiating B
 /  Cells When Complemented with TbMSP-B (Lanes 1–
3) but Not When Complemented with TbMSP-BE233D (Lanes 4–6)
Aliquots of the culture medium were collected as previously described
and probed in a western blot with antiserum directed against VSG221 (a
VSG221).
doi:10.1371/journal.ppat.0030150.g010
Figure 9. Complementation of B
 /  Cells with TbMSP-B Encoded on an Integrated Plasmid
BSF B
 / cells were stably transfected with linearized pLEW82/TbMSP-B or pLEW82/TbMSP-BE233D expression plasmid and stimulated to differentiate as
previously described except that 1 lg tetracycline/ml was added at times 0 and 48 h to induce TbMSP-B or TbMSP-BE233D expression from the
integrated plasmid. Extracts prepared from cells collected at the indicated times were probed in western blots with antiserum against (A) TbMSP-B (a
TbMSP-B) and (B) VSG221 (a VSG221). The lane labeled PRO contains an extract of PRO cells grown continuously at 26 8C in PRO medium.
doi:10.1371/journal.ppat.0030150.g009
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of protease activity (Figure 3A). Interestingly, TbMSP-B could
cleave a casein substrate in the zymogram gel, but did not
yield a proteolytic band in a gelatin zymogram gel, as does
Leishmania MSP. This observation provides a starting point
for assessing TbMSP-B’s substrate and sequence speciﬁcity.
Initially our differentiation experiments involved the
direct transfer of logarithmically growing BSF cells at 37 8C
to PRO medium at 26 8C supplemented with 3 mM cis-
aconitate and 3 mM citrate [24]. In these experiments,
decreasing amounts of VSG were detected in WT cell extracts
throughout the ﬁrst 4 d of differentiation (not shown). We
subsequently changed the differentiation protocol to ﬁrst
stimulate the transformation of logarithmic, long, slender
BSF cells to the non-proliferating, short, stumpy form by
adding a membrane-soluble cAMP [17] prior to transfer to
differentiation medium. This alternative differentiation con-
dition, which resulted in a more synchronized differentiation
in which the VSG was fully released from the WT cells by 48 h,
was used in all of the experiments described here.
PLC
 /  Cell Differentiation
Deletion of the GPI-PLC genes from the genome of BSF
cells led to a delay in loss of VSG from differentiating cells
(PLC
 /  in Figures 6B and 7). This delayed loss differs
somewhat from an earlier observation by Webb et al. [16], in
which another PLC
 /  cell line exhibited full release of VSG
during differentiation. This disparity could be due to several
factors, including differences in the two laboratory cell lines,
which express different VSGs. The EATR 1125 trypanosome
cell line utilized in [16] expressed a VSG(s) that cross reacted
with antibodies against AnTat 1.1, 1.2, and 1.3, whereas the
BSF cells used here express MITat 1.2 (VSG221). These VSG
proteins are members of different VSG domain types, with
AnTat 1.1 being a domain type 1 variant and MITat 1.2 a
domain type 2 variant [6,25]. It has been proposed that
removal of VSG during differentiation might use different
mechanisms depending on the type of VSG present on the
cell surface [7].
Examination of the culture medium of differentiating cells
also demonstrates that GPI-PLC is responsible for the release
of VSG into the medium during differentiation. The super-
natants from both BSF PLC
 /  and differentiating PLC
 / 
cells do not contain the VSG protein recognized by the anti-
CRD antibody, the hallmark of PLC cleavage (Figure 8B), but
the medium does contain full-length, or nearly full-length,
VSG protein of approximately 48 kDa, suggesting there is an
additional method of VSG release separate from GPI-PLC
and TbMSP-B.
TbMSP-B
 /  Cell Differentiation
The absence of TbMSP-B in differentiating cells led to a
delay in VSG loss, similar to that observed with PLC
 /  cells
(Figure 7), and correlated with the absence of the proteolyti-
cally cleaved VSG fragment in the culture medium (Figure 8).
This 37-kDa VSG fragment did not react with anti-CRD
antibody and therefore likely represents the N-terminal
portion of the protein. Its absence from the TbMSP-B
 / 
cell lines and its reappearance in cells when a TbMSP-B gene
was reintroduced into the genome (Figure 9) conﬁrms
TbMSP-B’s role in generating the smaller VSG fragment.
The exact site of its VSG221 cleavage remains to be
determined. One cleavage constraint is that TbMSP-B and
the VSG are both GPI-anchored to the membrane, so the
catalytic site of TbMSP-B may have access to only certain
segments of the VSG in vivo. It is also worth noting that the
peptide substrate speciﬁcity of Leishmania MSP has been
extensively studied and found to be relatively non-speciﬁc
[26,27].
TbMSP-B
 /  PLC
 /  Cell Differentiation
The slowed loss of VSG from each of the single gene knock-
out cell lines was exacerbated when both TbMSP-B and GPI-
PLC were absent from the cells. The VSG levels in extracts
after 96 h of differentiation were not additive in this doubly
deleted cell line; instead, TbMSP-B and GPI-PLC appear to
act synergistically. At 96 h post-differentiation, the B
 /  and
PLC
 /  cells have 5% and 16% of the VSG remaining,
whereas the B
 / PLC
 / cells have 60% remaining (Figure 7).
Currently there is no reason to expect that these two proteins
interact in a cooperative manner during differentiation, but
both can act to remove the VSG in a step essential for
completion of the life cycle. When additional localization
Figure 11. VSG Levels during BSF-to-PRO Differentiation in the Presence
of Cysteine Protease Inhibitors
WT (A) and B
 /  PLC
 /  (B) BSF cells were stimulated to differentiate to
PRO cells as described except that 2 lM concentrations of the inhibitors
P27 and K11777 were either added or not added (no cysPI) to the PRO
differentiation medium at time 0. Cells were collected at the indicated
times and extracts analyzed by western blots for VSG and tubulin, similar
to the blots shown in Figure 6B and 6E. VSG levels were quantitated at
each time point, the VSG intensities were normalized to the tubulin
levels, and the initial VSG levels (0 h) were set at 100%, similar to that
shown in Figure 7. The VSG level shown for each time point is a
percentage of initial VSG level. In WT cells (A), P27 and K11777 interfere
with the loss of about 20% and 10% of the VSG, respectively, at 96 h,
whereas in B
 /  PLC
 /  cells (B) the cysteine protease inhibitors do not
have a detectable effect.
doi:10.1371/journal.ppat.0030150.g011
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proximity of these two proteins can be addressed.
Virtually no change occurs in the amount of VSG in
extracts of B
 /  PLC
 /  cells between 48 and 96 h of
differentiation (Figure 7); it remains at about 60%. During
this time the cells have acquired a large amount of EP-
procyclin, ceased to divide, and assumed an abnormal
morphology (Figures 5B, 5F, and 6C). We have not examined
these B
 /  PLC
 /  cells further to see whether, in addition to
the acquisition of EP-procyclin, they have undergone the
metabolic changes associated with differentiation to PRO
cells. However, it is likely these cells cannot cope with the
massive amount of EP-procyclin being made at a time when
they are unable to eliminate 60% of their VSG to make room
for the EP-procyclin on the surface. The result is that the cells
shut down cell division, yet remain viable in the PRO medium
for several days. Eventually, the cells die (not shown).
Another point is that even in the absence of TbMSP-B and
GPI-PLC, about 40% of the VSG is lost by 48 h of
differentiation (Figure 7). Some of this VSG loss is likely
due to degradation and/or internalization [23], but some may
also be due to other unknown cellular components that might
contribute to VSG loss. Consistent with this possibility is the
fact that the medium of B
 /  PLC
 /  cells contains full-
length, or nearly full-length, VSG molecules of about 48 kDa
that do not have the CRD (Figure 8), and thus are not the
result of cleavages by TbMSP-B and GPI-PLC. We investigated
whether cysteine proteases might contribute to this 40% loss,
as was suggested by another report [22]. We conﬁrmed that
indeed inhibitors of cysteine proteases prevent loss of some
VSG from differentiating WT cells either directly or
indirectly (Figure 11A), but they did not interfere with that
40% loss of VSG from differentiating B
 /  PLC
 /  cells
(Figure 11B). Again, it is worth noting that these experiments
were conducted with a different BSF cell line expressing a
different VSG than were the original cysteine protease
inhibitor studies [22], and there may be VSG-dependent
variability in the mechanisms of release. Thus, we conclude
that TbMSP-B and GPI-PLC are clearly involved in the
cellular strategy for removing VSG quickly during BSF-to-
PRO differentiation, but the trypanosome may have addi-
tional speciﬁc mechanisms designed to achieve full VSG
release in a timely manner [7].
Materials and Methods
Trypanosome strains and culture conditions. The T. brucei BSF
‘‘single marker’’ (SM) trypanosome cell line (T7RNAPol TetR NEO)
and the PRO 29–13 cell line (T7RNAPol NEO TetR HYG) were gifts
from G. A. M. Cross (Rockefeller University, New York). Both of these
cell lines constitutively express T7 RNA polymerase and the
tetracycline repressor. BSF SM cells were maintained in HMI-9
medium [28] supplemented with 10% heat-inactivated fetal calf
serum (HIFCS), and PRO 29–13 cells were maintained in SDM-79
medium [9] supplemented with 10% HIFCS.
The pLEW82 expression plasmid for T. brucei [29] was a gift from G.
A. M. Cross. The TbMSP-B coding sequence was subcloned into
pLEW82 at its unique HindIII and BamHI restriction sites. The
resultant plasmid was linearized at its unique NotI site and stably
integrated into the T. brucei rDNA spacer region for subsequent
tetracycline-induced expression of TbMSP-B. For plasmid trans-
fections into BSF cells, the cells were electroporated [30] with 10 lg
NotI-linearized plasmid, and stable transfectants were selected in
medium containing 5 lg G418/ml, 5 lg phleomycin/ml, 5 lg
hygromycin/ml, and 0.5 lg puromycin/ml under conditions described
previously [10]. PRO cells were also transfected with 10 lg NotI-
linearized plasmid as described [31], and stable transfectants were
selected in medium containing 15 lg G418/ml and 2.5 lg phleomycin/
ml.
Differentiation of bloodstream trypanosomes. BSF cells were
stimulated to transform from dividing long, slender cells to non-
dividing short, stumpy cells by the addition of the membrane-
permeable derivative of cAMP, 8-(4-chlorophenylthio)-cAMP
(pCPTcAMP), to a ﬁnal concentration of 0.4 mM in HMI-9 medium
þ 10% HIFCS media for 48 h [17]. After 48 h, the short, stumpy cells
were centrifuged from the BSF medium and resuspended in SDM-79
mediumþ10% HIFCS supplemented with 3 mM cis-acontitate/3 mM
citrate to induce differentiation to the PRO form [24]. Cysteine
protease inhibitors P27 (morpholinourea-phenylalanine homophe-
nylalanine-benz-a-pyrone) and K11777 (N-methyl-piperazine-phenyl-
alanine-homophenylalanine-vinylsulfone-phenyl) (gifts from James
McKerrow, University of California at San Francisco) were added to
SDM-79 supplemented with cis-aconitate and citrate at a concen-
tration of 2 lM during differentiation for experiments described in
Figure 10.
Protein extracts, supernatant collection, and western blot analysis.
BSF and PRO cells were collected via centrifugation followed by a
wash in 1x PBS. Total protein extracts were prepared by resuspend-
ing cell pellets in 1x Laemmli sample buffer and boiling for 5 min.
Protein extracts were separated by SDS-PAGE and analyzed by
western blot [32]. In addition to the antiserum directed against
recombinant TbMSP-B, other antisera used in the western blots were
directed against HSP-70 and BiP (both kind gifts from Jay Bangs,
University of Wisconsin-Madison), VSG221 (the kind gift of George
Cross), EP-procyclin and GPEET-procyclin (both kind gifts from
Terry Pearson, University of Victoria), the CRD of the GPI anchor
(the kind gift of Paul Englund, Johns Hopkins University), and a-
tubulin (AB-1, Oncogene). Secondary antibodies linked to horse-
radish peroxidase were used to detect proteins via chemilumines-
cence. Media supernatants were collected from cell cultures as
previously described [7]. Brieﬂy, cell cultures were centrifuged for 2
min to pellet cells and the supernatant was added in a 10:1 ratio to a
solution containing 1% NP40, 0.5% deoxycholate, and 0.1% SDS. A
100x protease inhibitor cocktail (Sigma) was added to 1x ﬁnal
concentration and samples frozen at 20 8C until used. Samples were
then analyzed by western blot as described above.
Preparation and afﬁnity puriﬁcation of anti-TbMSP-B antiserum.
The TbMSP-B coding sequence from nucleotides 157 through 1125
was PCR-ampliﬁed from plasmid pLEW82/TbMSP-B using primers
designed with a BamHI site in the 59 primer and an XhoI site in the 39
primer. The PCR fragment was subcloned into pCR2.1-Topo
(Invitrogen) and excised using BamHI and XhoI. The puriﬁed
TbMSP-B coding sequence was then subcloned into puriﬁed
BamHI/XhoI-digested pET32A plasmid (Novagen). The pET32A/
TbMSP-B plasmid was transformed into E. coli DE3 cells (Novagen)
and induced to overexpress the pET32A/TbMSP-B chimeric protein
with 1 mM IPTG as per the Novagen pET System Manual. The
pET32A/TbMSP-B fusion protein was insoluble in DE3 cells and
localized to inclusion bodies. Inclusion bodies were isolated as
described [33] and injected into a New Zealand White rabbit at 2 mg/
injection, supplemented with Freud’s Complete Adjuvant [34]. Two
additional booster injections were made at 4 wk and 6 wk before
complete collection of antisera.
Afﬁnity puriﬁcation of the anti-TbMSP-B antiserum was per-
formed using HIS-puriﬁed pET32A/TbMSP-B fusion protein. The
fusion protein was isolated using a Novagen HIS-Bind Kit. The HIS-
puriﬁed protein was electrophoresed on an SDS-PAGE gel and
transferred to a PVDF membrane. A strip of membrane correspond-
ing to the size of pET32A/TbMSP-B fusion protein was cut from the
membrane and used in the afﬁnity puriﬁcation. The PVDF strip with
the bound fusion protein was incubated with the rabbit anti-TbMSP-
B serum and washed ﬁrst in 500 mM NaCl/50 mM Tris-HCl (pH 7.4),
followed by washes in 100 ml NaCl/50 mM Tris-HCl (pH 7.4).
Antibody bound to the membrane was removed with 50 mM glycine
(pH 2.5) at 4 8C and brought back to pH 7.4 with 2 M Tris-HCl [35].
Afﬁnity-puriﬁed antiserum (a-TbMSP-B) was stored at 4 8C for use.
Zymogram gels. PRO cells stably transfected with linearized
pLEW82/TbMSP-B expression plasmid were cultured in the absence
or presence of 1 lg tetracycline/ml to overexpress TbMSP-B for 24 h.
Cell samples were collected and washed twice in 1x PBS. Whole cells
were lysed in a non-reducing, denaturing sample buffer and passaged
through a 27-gauge needle three times prior to running on a Bio-Rad
12% casein zymogram gel at 4 8C. The zymogram gel was
subsequently washed twice in 2% TX-100, rinsed brieﬂy in double-
deionized H2O, and washed once in Bio-Rad Zymogram development
buffer, followed by incubation in development buffer at 37 8C [36].
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acetic acid revealed proteolytic bands.
Construction of TbMSP-B and GPI-PLC gene-deletion plasmids.
The TbMSP-B and GPI-PLC gene-deletion plasmids were generated
using a core plasmid construct containing the rRNA promoter, actin
(ACT)5 9 UTR, and the bleomycin-resistance (BLE) gene from the
RNA interference plasmid p2T7
tiA/GFP [37]. The genes encoding
hygromycin phosphotransferase (HYG), streptothricin acetyltransfer-
ase (SAT), and puromycin acetyltransferase (PUR) were used to
replace the BLE gene at unique restriction sites introduced during
cloning.
A 0.4-kb genomic sequence preceding the cluster of four tandem
TbMSP-B genes on chromosome VIII was PCR-ampliﬁed with primers
homologous to the sequences about 80 bp and 480 bp upstream of the
start codon of the ﬁrst TbMSP-B gene in the cluster. A 2.26-kb
genomic sequence following the cluster was PCR-ampliﬁed with
primers homologous to portions of the 39 UTR and intergenic region
about 550 bps to 2,810 bps downstream of the last TbMSP-B gene in
the cluster. These upstream and downstream sequences were
subcloned in the gene-deletion plasmid to direct recombination
and removal of the entire TbMSP-B four-gene cluster. Genomic
sequences ﬂanking GPI-PLC were generated similarly to the TbMSP-B
target sequences, but contained ;0.84 kb upstream sequence and
;1.14 kb downstream sequence designed to replace the single copy
GPI-PLC on chromosome II.
Southern blots. Genomic DNAs isolated from BSF cells were
digested with restriction enzymes, separated on a 1% agarose gel,
depurinated in 0.25 M HCl, denatured in 0.4 M NaOH, transferred to
nylon membrane (Hybond, Amersham International), and immobi-
lized one time by UV irradiation. [
32P]-radiolabeled DNA probe was
added to a 50% formamide, 6X SSC, 10X Denhardt’s solution, 0.2%
SDS hybridization solution with 150 lg single-stranded salmon sperm
DNA/ml at 50 8C overnight. Final washing conditions were in 0.1%
SSC, 0.1% SDS at 60 8C.
TX-114 extraction, biotin labeling, immunoprecipitation. PRO cells
were extracted with TX-114 as previously described [36] and aqueous
and detergent phases were electrophoresed on SDS-PAGE in a 3:5
ratio with 2x SDS reducing sample buffer. Western blot analysis using
the protocol described above was performed to visualize TbMSP-B
and HSP-70 proteins in each phase. Biotin labeling (EZ-Link Sulfo-
NHS-Biotin, Pierce) of PRO cells was conducted according to EZ-Link
instructions and cells were lysed in 0.5% TX-100 for 30 min. The
supernatant was then pre-cleared using rabbit pre-immune serum
and immunoprecipitated with afﬁnity-puriﬁed TbMSP-B antiserum,
HSP-70, or BiP antisera [38]. Protein bound to the immunoprecipi-
tating antiserum was released by boiling in 1x SDS Laemmli sample
buffer. Biotin-labeled proteins were separated on a SDS-PAGE gel,
blotted to nitrocellulose and the membrane incubated with a
streptavidin-HRP antibody (Sigma). HSP-70 and BiP immunopreci-
pitations were also analyzed in western blots probed with antisera
directed against HSP-70 and BiP.
Supporting Information
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UniProt accession numbers (http://www.ebi.uniprot.org/) for the main
T. brucei proteins utilized or mentioned in this research are a-tubulin
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for the genes deleted from the T. brucei genome in this research are
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